Back to Search
SHANNON MARIE CARBAJAL, M.D.
M.D.
Internal Medicine Physician
NPI: 1598129587IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
A157535(CA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2015
Research & Publications (18)
Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues.
PMID 19138937·Cancer Prev Res (Phila)·2008
7-preclinical
DNA structure-induced genomic instability in vivo.
PMID 19066276·J Natl Cancer Inst·2008
7-preclinical
IKKalpha is required to maintain skin homeostasis and prevent skin cancer.
PMID 18772111·Cancer Cell·2008
7-preclinical
Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor I levels.
PMID 18483250·Cancer Res·2008
7-preclinical
Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis.
PMID 18453544·Carcinogenesis·2008
7-preclinical
Constitutively active Akt induces ectodermal defects and impaired bone morphogenetic protein signaling.
PMID 17959825·Mol Biol Cell·2008
7-preclinical
Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
PMID 17700521·Oncogene·2008
7-preclinical
Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis.
PMID 18006833·Cancer Res·2007
7-preclinical
Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model.
PMID 17440093·Cancer Res·2007
7-preclinical
Role of PI3K/Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion.
PMID 16086373·Mol Carcinog·2005
7-preclinical
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.
PMID 15592573·Nat Med·2005
7-preclinical
Development of transgenic mice that inducibly express an active form of c-Src in the epidermis.
PMID 15264211·Mol Carcinog·2004
7-preclinical
Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.
PMID 15059889·Cancer Res·2004
7-preclinical
Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis.
PMID 12941801·Cancer Res·2003
7-preclinical
Overexpression of a constitutively active form of c-src in skin epidermis increases sensitivity to tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
PMID 11870880·Mol Carcinog·2002
7-preclinical
Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma.
PMID 11585718·Cancer Res·2001
7-preclinical
Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
PMID 10980598·Oncogene·2000
7-preclinical
Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion.
PMID 10749124·Cancer Res·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 26600 CACTUS AVE STE 300
MORENO VALLEY, CA 92555 - Phone
- (951) 988-9500
Quick Facts
- NPI
- 1598129587
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 11
- Publications
- 18
Are you this provider?
Claim Your Profile